---
figid: PMC9130392__12672_2022_497_Fig2_HTML
pmcid: PMC9130392
image_filename: 12672_2022_497_Fig2_HTML.jpg
figure_link: /pmc/articles/PMC9130392/figure/Fig2/
number: Fig. 2
figure_title: ''
caption: mTOR gene expression levels among Black women vs. White women, stratified
  by molecular subtypes.Â A Luminal, p-value = 0.0003; HER2+, p-value = 0.1696; Triple-negative,
  p-value = 0.0028, B Luminal, p-value = 0.8275; HER2+, p-value = 0.8599; Triple-negative,
  p-value = 0.9744, C Luminal, p-value = 0.7066; HER2+, p-value = 0.3314; Triple-negative,
  p-value = 0.8613, D Luminal, p-value = 0.0348; HER2+, p-value = 0.3720; Triple-negative,
  p-value = 0.1132, E Luminal, p-value = 0.7842; HER2+, p-value = 0.6807; Triple-negative,
  p-value = 0.3711
article_title: mTOR pathway gene expression in association with race and clinicopathological
  characteristics in Black and White breast cancer patients.
citation: Mmadili N. Ilozumba, et al. Discov Oncol. 2022 Dec;13:34.
year: '2022'

doi: 10.1007/s12672-022-00497-y
journal_title: Discover. Oncology
journal_nlm_ta: Discov Oncol
publisher_name: Springer US

keywords:
- mTOR
- Gene expression
- Breast cancer
- Race
- Clinicopathological characteristics

---
